Bezafibrate add-on therapy in high-risk primary biliary cholangitis is associated with prolonged predicted survival even in patients with incomplete biochemical improvements

被引：1
作者：
Corpechot, Christophe [1 ,2 ]
Rousseau, Alexandra [3 ]
Lemoinne, Sara [1 ,2 ]
Farid, Gaouar [1 ]
Ben Belkacem, Karima [1 ]
Poupon, Raoul [1 ]
Chazouilleres, Olivier [1 ,2 ]
机构：
[1] St Antoine Hosp, AP HP, Reference Ctr Inflammatory Biliary Dis & Autoimmu, Paris, France
[2] Sorbonne Univ, INSERM, UMR S938, Paris, France
[3] St Antoine Hosp, AP HP, Clin Res Platform East Paris, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30759-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-009
引用
收藏
页码：E386 / E387
页数：2
相关论文
共 40 条
  • [31] Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients.
    Gatselis, Nikolaos K.
    Goet, Jorn C.
    Zachou, Kalliopi
    Lammers, Willem J.
    Janssen, Harry L.
    Hirschfield, Gideon
    Corpechot, Christophe
    Lindor, Keith D.
    Invernizzi, Pietro
    Mayo, Marlyn J.
    Battezzati, Pier Maria
    Floreani, Annarosa
    Pares, Albert
    Ligoura, Vasiliki
    Nevens, Frederik
    Mason, Andrew
    Kowdley, Kris V.
    Ponsioen, Cyriel Y.
    Bruns, Tony
    Thorburn, Douglas
    Verhelst, Xavier
    Harms, Maren H.
    van Buuren, Henk R.
    Hansen, Bettina E.
    Dalekos, George
    HEPATOLOGY, 2017, 66 : 169A - 170A
  • [32] Efficacy of add-on treosulfan and melphalan high-dose therapy in patients with high-risk metastatic Ewing sarcoma: Report from the International Ewing 2008R3 trial.
    Dirksen, Uta
    Bhadri, Vivek
    Brichard, Benedicte
    Butterfass-Bahloul, Trude
    Cyprova, Sona
    Faldum, Andreas
    Gelderblom, Hans
    Hardes, Jendrik
    Hauser, Peter
    Havemann, Lianne
    Hjorth, Lars
    Juergens, Heribert
    Kanerva, Jukka
    Kuehne, Thomas
    Ladenstein, Ruth Lydia
    Raciborska, Anna
    Rascon, Jelena
    Timmermann, Beate
    Ranft, Andreas
    Koch, Raphael
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Adjuvant Chemotherapy in High-Risk Prostate Cancer Patients after Primary Local Therapy: Recurrence, Metastasis, and Survival - A Meta-Analysis
    Zhang, Qiang
    Huang, Jing
    Xie, Chaofan
    Wu, Tao
    UROLOGIA INTERNATIONALIS, 2021, 105 (5-6) : 394 - 401
  • [34] Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors
    Shurell-Linehan, Elizabeth
    DiPardo, Benjamin J.
    Elliott, Irmina A.
    Graham, Danielle S.
    Eckardt, Mark A.
    Dry, Sarah M.
    Nelson, Scott D.
    Singh, Arun S.
    Kalbasi, Anusha
    Federman, Noah
    Bernthal, Nicholas M.
    Eilber, Fritz C.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (05): : 426 - 431
  • [35] Loss of Tumor Suppressor DAB2IP Correlates With Decreased Biochemical Recurrence-free Survival in High-Risk Prostate Cancer Patients Treated With Radiation Therapy
    Kim, D.
    Tumati, V.
    Pistenmaa, D.
    Kapur, P.
    Xie, X.
    Hannan, R.
    Jacobs, C.
    Straka, C.
    Hsieh, J.
    Saha, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S714 - S714
  • [36] Significant interaction between testosterone recovery (TR) and biochemical progression-free survival (BPFS) in intermediate and high-risk patients with prostate cancer treated with radiation therapy (RT) and androgen deprivation therapy (ADT)
    Shasha, D.
    Nabhani, T.
    Rauth, S. J.
    Salant, R.
    Harrison, L. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [37] Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients
    Flammia, R. S.
    Lavigne, D.
    Tian, Z.
    Saad, F.
    Anceschi, U.
    Gallucci, M.
    Leonardo, C.
    Preisser, F.
    Mandel, P.
    Chun, F. K. H.
    Karakiewicz, P., I
    Delouya, G.
    Taussky, D.
    Hoeh, B.
    CLINICAL ONCOLOGY, 2023, 35 (01) : E77 - E84
  • [38] Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
    Carabante, Maria Isabel Benitez
    Bueno, David
    Garcia, Laura Alonso
    Torija, Ivan Lopez
    Marsal, Julia
    Navarro, Jose Maria Fernandez
    Oficialdegui, Maria Luz Uria
    Panesso, Melissa
    Molina, Blanca
    Bieler, Cristina Belendez
    Palomo, Pilar
    Martinez, Antonio Perez
    Diaz-de-Heredia, Cristina
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (06): : 601.e1 - 601.e13
  • [39] Development of Novel Nomograms to Predict 5-and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
    Utsumi, Takanobu
    Suzuki, Hiroyoshi
    Wakatsuki, Masaru
    Kobayashi, Kana
    Okato, Atsushi
    Nakajima, Mio
    Aoki, Shuri
    Sumiya, Taisuke
    Ichikawa, Tomohiko
    Akakura, Koichiro
    Tsuji, Hiroshi
    Yamada, Shigeru
    Ishikawa, Hitoshi
    APPLIED SCIENCES-BASEL, 2025, 15 (02):
  • [40] The use of negative pressure wound therapy as a dual closure and splinting device is associated with rapid delayed primary wound closure in high-risk diabetic patients following digital amputation: a case series
    Iannella, S. M.
    McInnes, W.
    Fitridge, R.
    Dawson, J.
    WOUND PRACTICE AND RESEARCH, 2015, 23 (01): : 4 - 7
1234